Skip to main content
. 2017 Aug 4;34(9):2083–2092. doi: 10.1007/s12325-017-0592-x

Fig. 2.

Fig. 2

Final model adjusted for baseline differences showing healthcare costs utilization associated with patients newly initiated on basal insulin. Generalized linear model was used to analyze healthcare costs. a P < 0.001